サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：たこつぼ症候群治療薬市場：治療法別、投与経路別、流通チャネル別、世界予測（2022-2032年）
市場調査レポート
商品コード
1370614

たこつぼ症候群治療薬市場：治療法別、投与経路別、流通チャネル別、世界予測（2022-2032年）

Takotsubo Syndrome Therapeutics Market-By Therapy (DAPT, Anticoagulants, Beta-blockers, Statins, Diuretics, ACE Inhibitors), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital, Retail Pharmacies), Global Forecast, (2022-2032)
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
たこつぼ症候群治療薬市場：治療法別、投与経路別、流通チャネル別、世界予測（2022-2032年）
出版日: 2023年08月23日
発行: Global Market Insights Inc.
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のたこつぼ症候群治療薬市場は2023年から2032年にかけてCAGR 4.7％で成長する見通しです。

病態への理解が深まり、診断技術が向上したことで、より正確でタイムリーな治療が可能になり、市場の成長を後押ししています。ヘルスケア専門家や一般住民の間で同症候群に対する認識が高まり、早期介入につながっており、これが業界拡大の原動力となることが期待されます。

さらに、ストレス関連心疾患の根本的な原因に対処するための薬物療法や治療法の開発も、事業の成長に寄与すると考えられます。現代社会におけるストレス関連疾患の罹患率の上昇は、効果的なたこつぼ症候群治療薬への需要を高め、市場拡大を後押ししています。

2022年2月、ガルデルマと太郎製薬は、太郎製薬がガルデルマからアルケミー（旧名プロアクティブ・カンパニー（TPC））を買収する正式契約を発表しました。

治療法に基づくと、抗凝固剤セグメントは、血栓性合併症に関連する病態を管理する必要性により、分析期間中に4.8%のCAGRを反映します。抗凝固剤は、血栓を予防し、脳卒中やその他の心血管系合併症のリスクを最小限に抑えることで、患者の治療と転帰を向上させる上で極めて重要です。

非経口投与経路セグメントは、2023～2032年のCAGRが4.3％になると予想されています。迅速かつ直接的なドラッグデリバリーの必要性が、このセグメントの成長を促進すると思われます。非経口投与は、急性たこつぼエピソードを管理し、効果的な症状緩和を達成する上で極めて重要な、即時かつ正確な薬物分配を保証します。

流通チャネル別では、小売薬局の2032年までのCAGRは4.4%です。小売薬局が提供するアクセスのしやすさと患者の利便性が、このセグメントの成長を促進すると思われます。小売薬局は処方薬へのアクセスを容易にし、患者が必要な治療薬を入手し、治療レジメンを遵守することをより便利にし、患者の転帰を改善します。

地域別では、アジア太平洋地域のたこつぼ症候群治療薬市場のCAGRは予測期間を通じて5.4%です。認知度の向上、ヘルスケアインフラの整備、心血管疾患罹患率の上昇、高齢化が同地域の産業を後押しします。ヘルスケアの優先事項の進化が治療法の研究開発を促進し、成長をさらに加速させる。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 たこつぼ症候群治療薬の業界考察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 老年人口の増加
      • 診断技術の進歩
      • 個別化医療とオーダーメイド治療の進歩
      • 心血管疾患の有病率の増加
    • 業界の潜在的リスク＆課題
      • たこつぼ症候群の根本的なメカニズムの理解が不十分
      • 具体的な治療ガイドラインの欠如
      • 高額な治療費
  • 成長可能性分析
  • COVID-19インパクト分析
  • 規制状況
  • 技術情勢
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 企業ポジショニングマトリックス
  • 主要市場プレーヤーの競合分析
  • 戦略展望マトリックス

第5章 たこつぼ症候群治療薬の市場規模・予測：治療法別

  • 主要動向：治療法別
  • 二重抗血小板療法（DAPT）
  • 抗凝固薬
  • β遮断薬
  • アンジオテンシン変換酵素（ACE）阻害薬
  • アルドステロン受容体拮抗薬
  • スタチン
  • 利尿薬

第6章 たこつぼ症候群治療薬の市場規模・予測：投与経路別

  • 主要動向：投与経路別
  • 経口
  • 非経口

第7章 たこつぼ症候群治療薬の市場規模・予測：流通チャネル別

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他の流通チャネル

第8章 たこつぼ症候群治療薬の市場規模・予測：地域別

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第9章 企業プロファイル

  • Sanofi SA
  • Pfizer Inc.
  • AbbVie Inc.
  • ANI Pharmaceuticals, Inc.
  • Novartis AG
  • GlaxoSmithKline plc
  • Taro Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals LLC.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
図表

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by therapy (2022)
  • TABLE 3 Market share, by route of administration (2022)
  • TABLE 4 Market share, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global takotsubo syndrome therapeutics market size, 2018-2022, (USD Million)
  • TABLE 7 Global takotsubo syndrome therapeutics market size, 2023-2032, (USD Million)
  • TABLE 8 Global takotsubo syndrome therapeutics market size, by region, 2018-2022 (USD Million)
  • TABLE 9 Global takotsubo syndrome therapeutics market size, by region, 2023-2032 (USD Million)
  • TABLE 10 Global takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 11 Global takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 12 Global takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 13 Global takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 14 Global takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 15 Global takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Dual antiplatelet therapy (DAPT) market size, 2018-2022 (USD Million)
  • TABLE 18 Dual antiplatelet therapy (DAPT) market size, 2023-2032 (USD Million)
  • TABLE 19 Anticoagulants market size, 2018-2022 (USD Million)
  • TABLE 20 Anticoagulants market size, 2023-2032 (USD Million)
  • TABLE 21 Beta-blockers market size, 2018-2022 (USD Million)
  • TABLE 22 Beta-blockers market size, 2023-2032 (USD Million)
  • TABLE 23 Angiotensin-converting enzyme (ACE) inhibitors market size, 2018-2022 (USD Million)
  • TABLE 24 Angiotensin-converting enzyme (ACE) inhibitors market size, 2023-2032 (USD Million)
  • TABLE 25 Aldosterone receptor blockers market size, 2018-2022 (USD Million)
  • TABLE 26 Aldosterone receptor blockers market size, 2023-2032 (USD Million)
  • TABLE 27 Statins market size, 2018-2022 (USD Million)
  • TABLE 28 Statins market size, 2023-2032 (USD Million)
  • TABLE 29 Diuretics market size, 2018-2022 (USD Million)
  • TABLE 30 Diuretics market size, 2023-2032 (USD Million)
  • TABLE 31 Oral market size, 2018-2022 (USD Million)
  • TABLE 32 Oral market size, 2023-2032 (USD Million)
  • TABLE 33 Parenteral market size, 2018-2022 (USD Million)
  • TABLE 34 Parenteral market size, 2023-2032 (USD Million)
  • TABLE 35 Hospital pharmacies market size, 2018-2022 (USD Million)
  • TABLE 36 Hospital pharmacies market size, 2023-2032 (USD Million)
  • TABLE 37 Retail pharmacies/ drug stores market size, 2018-2022 (USD Million)
  • TABLE 38 Retail pharmacies/ drug stores market size, 2023-2032 (USD Million)
  • TABLE 39 Other distribution channels market size, 2018-2022 (USD Million)
  • TABLE 40 Other distribution channels market size, 2023-2032 (USD Million)
  • TABLE 41 North America takotsubo syndrome therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 42 North America takotsubo syndrome therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 43 North America takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 44 North America takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 45 North America takotsubo syndrome therapeutics market size, route of administration, 2018-2022 (USD Million)
  • TABLE 46 North America takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 47 North America takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 48 North America takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 49 U.S. takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 50 U.S. takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 51 U.S. takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 52 U.S. takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 53 U.S. takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 54 U.S. takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 55 Canada takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 56 Canada takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 57 Canada takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 58 Canada takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 59 Canada takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 60 Canada takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 61 Europe takotsubo syndrome therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 62 Europe takotsubo syndrome therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 63 Europe takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 64 Europe takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 65 Europe takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 66 Europe takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 67 Europe takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 68 Europe takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 69 Germany takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 70 Germany takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 71 Germany takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 72 Germany takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 73 Germany takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 74 Germany takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 75 UK takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 76 UK takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 77 UK takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 78 UK takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 79 UK takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 80 UK takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 81 France takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 82 France takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 83 France takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 84 France takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 85 France takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 86 France takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 87 Spain takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 88 Spain takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 89 Spain takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 90 Spain takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 91 Spain takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 92 Spain takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 93 Italy takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 94 Italy takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 95 Italy takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 96 Italy takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 97 Italy takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 98 Italy takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 99 Rest of Europe takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 100 Rest of Europe takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 101 Rest of Europe takotsubo syndrome therapeutics market size, route of administration, 2018-2022 (USD Million)
  • TABLE 102 Rest of Europe takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 103 Rest of Europe takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 104 Rest of Europe takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 105 Asia Pacific takotsubo syndrome therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 106 Asia Pacific takotsubo syndrome therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 107 Asia Pacific takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 108 Asia Pacific takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 109 Asia Pacific takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 110 Asia Pacific takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 111 Asia Pacific takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 112 Asia Pacific takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 113 Japan takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 114 Japan takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 115 Japan takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 116 Japan takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 117 Japan takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 118 Japan takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 119 China takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 120 China takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 121 China takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 122 China takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 123 China takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 124 China takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 125 India takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 126 India takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 127 India takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 128 India takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 129 India takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 130 India takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 131 Australia takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 132 Australia takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 133 Australia takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 134 Australia takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 135 Australia takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 136 Australia takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 137 South Korea takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 138 South Korea takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 139 South Korea takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 140 South Korea takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 141 South Korea takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 142 South Korea takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 143 Rest of Asia pacific takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 144 Rest of Asia pacific takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 145 Rest of Asia Pacific takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 146 Rest of Asia Pacific takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 147 Rest of Asia Pacific takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 148 Rest of Asia Pacific takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 149 Latin America takotsubo syndrome therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 150 Latin America takotsubo syndrome therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 151 Latin America takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 152 Latin America takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 153 Latin America takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 154 Latin America takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 155 Latin America takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 156 Latin America takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 157 Brazil takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 158 Brazil takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 159 Brazil takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 160 Brazil takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 161 Brazil takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 162 Brazil takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 163 Mexico takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 164 Mexico takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 165 Mexico takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 166 Mexico takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 167 Mexico takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 168 Mexico takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 169 Rest of Latin America takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 170 Rest of Latin America takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 171 Rest of Latin America takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 172 Rest of Latin America takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 173 Rest of Latin America takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 174 Rest of Latin America takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 175 Middle East & Africa takotsubo syndrome therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 176 Middle East & Africa takotsubo syndrome therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 177 Middle East & Africa takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 178 Middle East & Africa takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 179 Middle East & Africa takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 180 Middle East & Africa takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 181 Middle East & Africa takotsubo syndrome therapeutics market size, by distribution channel, 20218-2022 (USD Million)
  • TABLE 182 Middle East & Africa takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 183 South Africa takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 184 South Africa takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 185 South Africa takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 186 South Africa takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 187 South Africa takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 188 South Africa takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 189 Saudi Arabia takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 190 Saudi Arabia takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 191 Saudi Arabia takotsubo syndrome therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 192 Saudi Arabia takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 193 Saudi Arabia takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 194 Saudi Arabia takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 195 Rest of Middle East & Africa takotsubo syndrome therapeutics market size, by therapy, 2018-2022 (USD Million)
  • TABLE 196 Rest of Middle East & Africa takotsubo syndrome therapeutics market size, by therapy, 2023-2032 (USD Million)
  • TABLE 197 Rest of Middle East & Africa takotsubo syndrome therapeutics market size, route of administration, 2018-2022 (USD Million)
  • TABLE 198 Rest of Middle East & Africa takotsubo syndrome therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 199 Rest of Middle East & Africa takotsubo syndrome therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 200 Rest of Middle East & Africa takotsubo syndrome therapeutics market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

  • FIG 1 Industry segmentation
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Takotsubo syndrome therapeutics market, 360o synopsis, 2018 -2032
  • FIG 7 Industry landscape, 2018-2032 (USD Million)
  • FIG 8 Growth potential analysis, by therapy
  • FIG 9 Growth potential analysis, by route of administration
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Growth potential analysis, by region
  • FIG 12 Porter's analysis
  • FIG 13 PESTEL analysis
  • FIG 14 Company matrix analysis, 2022
  • FIG 15 Strategic dashboard
目次
Product Code: 6535

Global Takotsubo syndrome therapeutics market will grow at 4.7% CAGR from 2023 to 2032. Better understanding of the condition and improved diagnostic techniques have led to more accurate and timely treatment, fueling market growth. Increased awareness of the syndrome among healthcare professionals and the general population has led to earlier intervention, which is expected to drive industry expansion.

Additionally, the development of medications and therapies for addressing the underlying causes of stress-related heart conditions will contribute to business growth. The rising incidence of stress-related disorders in modern society has heightened the demand for effective takotsubo syndrome therapeutics, propelling market expansion.

In February 2022, Galderma and Taro Pharmaceutical Industries Ltd. announced a formal agreement wherein Taro would acquire Alchemee, previously known as The Proactiv Company (TPC), from Galderma.

The overall market is categorized based on therapy, route of administration, distribution channel, and region.

Based on therapy, the anticoagulants segment will reflect a 4.8% CAGR during the analysis period, driven by the need to manage thrombotic complications associated with the condition. Anticoagulants are crucial in preventing blood clots and minimizing the risk of stroke or other cardiovascular complications, thereby enhancing patient care and outcomes.

The parenteral route of administration segment is expected to exhibit a 4.3% CAGR during 2023-2032. The need for rapid and direct drug delivery will foster growth in the segment. Parenteral administration ensures immediate and precise medication distribution, which is crucial in managing acute takotsubo episodes and achieving effective symptom relief.

Based on distribution channel, the retail pharmacies segment will depict a 4.4% CAGR through 2032. The accessibility and patient convenience offered by retail pharmacies will drive growth in the segment. Retail pharmacies offer easy access to prescribed medications, making it more convenient for patients to obtain necessary therapeutics and adhere to treatment regimens, improving patient outcomes.

Regionally, the Asia Pacific takotsubo syndrome therapeutics market will witness a 5.4% CAGR throughout the forecast period. Growing awareness, better healthcare infrastructure, rising cardiovascular disease prevalence, and an aging population will boost the region's industry. Evolving healthcare priorities drive therapeutic research and development, further spurring growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global takotsubo syndrome therapeutics market 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Therapy trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Distribution channel trends

Chapter 3 Takotsubo Syndrome Therapeutics Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing geriatric population
      • 3.2.1.2 Advancements in diagnostic techniques
      • 3.2.1.3 Advances in personalized medicine and tailored treatment
      • 3.2.1.4 Increasing prevalence of cardiovascular diseases
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited understanding of underlying mechanisms behind takotsubo syndrome
      • 3.2.2.2 Lack of specific treatment guidelines
      • 3.2.2.3 High cost of treatment
  • 3.3 Growth potential analysis
    • 3.3.1 By therapy
    • 3.3.2 By route of administration
    • 3.3.3 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company positioning matrix
  • 4.4 Competitive analysis of major market players
  • 4.5 Strategic outlook matrix

Chapter 5 Takotsubo Syndrome Therapeutics Market Size and Forecast, By Therapy (USD Million)

  • 5.1 Key trends, by therapy
  • 5.2 Dual antiplatelet therapy (DAPT)
  • 5.3 Anticoagulants
  • 5.4 Beta-blockers
  • 5.5 Angiotensin-converting enzyme (ACE) inhibitors
  • 5.6 Aldosterone receptor blockers
  • 5.7 Statins
  • 5.8 Diuretics

Chapter 6 Takotsubo Syndrome Therapeutics Market Size and Forecast, By Route of Administration (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Oral
  • 6.3 Parenteral

Chapter 7 Takotsubo Syndrome Therapeutics Market Size and Forecast, By Distribution Channel (USD Million)

  • 7.1 Key trends, by distribution channel
  • 7.2 Hospital pharmacies
  • 7.3 Retail pharmacies/ drug stores
  • 7.4 Other distribution channels

Chapter 8 Takotsubo Syndrome Therapeutics Market Size and Forecast, By Region (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Sanofi SA
  • 9.2 Pfizer Inc.
  • 9.3 AbbVie Inc.
  • 9.4 ANI Pharmaceuticals, Inc.
  • 9.5 Novartis AG
  • 9.6 GlaxoSmithKline plc
  • 9.7 Taro Pharmaceutical Industries Ltd.
  • 9.8 Amneal Pharmaceuticals LLC.
  • 9.9 Teva Pharmaceutical Industries Ltd.
  • 9.10 Sun Pharmaceutical Industries Ltd.